Associated Papers
Reassessing the role of the p.(Arg304Gln) missense AIP variant in pituitary tumorigenesis.
Loughrey PB et al.
European Journal of Endocrinology, 2025
40070360 (PubMed )
Supplement: lvaf044_supplementary_data.docx
In vivo bioassay to test the pathogenicity of missense human AIP variants.
Aflorei ED et al.
Journal of Medical Genetics, 2018
Risk category system to identify pituitary adenoma patients with AIP mutations.
Caimari F et al.
Journal of Medical Genetics, 2018
29440248 (PubMed )
Supplement: jmedgenet-2017-104957supp001.docx
Increased Population Risk of AIP-Related Acromegaly and Gigantism in Ireland.
Radian S et al.
Human Mutation, 2017
27650164 (PubMed )
Supplement: HUMU-38-78-s001.docx
Prevalence of AIP mutations in a series of Turkish acromegalic patients: are synonymous AIP mutations relevant?
Karaca Z et al.
Pituitary, 2015
AIP and its interacting partners.
Trivellin G et al.
The Journal of Endocrinology, 2011
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
Daly AF et al.
The Journal of Clinical Endocrinology and Metabolism, 2007
Select a paper to view details